Glaucoma
Conditions
Interventions
bimatoprost group:Use bimatoprost
travoprost group:Use travoprost
latanprost group:Use latanprost
tafluprost group:Use tafluprost
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Those who meet the diagnostic criteria of POAG or ocular hypertension in China; 2.Those who had never used prostaglandins had the latter after the elution period of other drugs.
Exclusion criteria
Exclusion criteria: 1.Previous eye surgery (except for cataract superemulsification) and eye trauma; 2.Chronic eye diseases (blepharoptosis, thyroid-related eye diseases, orbital tumors and other diseases that cause ocular protrusion or depression); 3.Wearing contact lenses; 4.Patients with unsuitable general conditions: for example, patients with bronchial asthma, patients with severe chronic obstructive pulmonary disease, bradycardia, patients with II or III degree atrioventricular block, patients with obvious heart failure and cardiogenic shock should not use ß-blockers, as well as patients with allergies to the selected drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pupil distance;degree of exophthalmus;margin reflex distance; | — |
Countries
China
Contacts
Public ContactNi Li
West China Hospital of Sichuan University
Outcome results
None listed